DUBLIN--(BUSINESS WIRE)--The "Allergic Conjunctivitis (AC) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of AC in the United States, EU5, and Japan.
The Allergic Conjunctivitis (AC) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
This segment of the Allergic Conjunctivitis report encloses the detailed analysis of marketed drugs and late stage pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
At present, there are mainly eight therapeutic classes of drugs contributing towards the market size of AC - Decongestants/Antihistamines, Corticosteroids, Topical Histamines, Systemic Histamines, Mast cell stabilizers (MCS), Immunomodulators, Nonsteroidal anti-inflammatory drugs (NSAIDs) and Dual acting Antihistamines/Mast cell stabilizers.
The Allergic Conjunctivitis market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
- Nicox Pharma - Allergan
- Aldeyra Therapeutics - Valeant
- ORA, Inc. - Novartis
- Ocular Therapeutix, Inc. - Pfizer
- Santen Pharma - Medpointe
- Faes Pharma - Bausche & Lombe
Key Topics Covered:
1. Key Insights
2. Allergic Conjunctivitis Market Overview at a Glance
3. Disease Background and Overview: Allergic Conjunctivitis (AC)
4. Epidemiology and Patient Population
5. Key Findings
6. Country Wise-Epidemiology of Allergic Conjunctivitis
7. Treatment Agorithm
8. Unmet needs
9. Marketed Drugs
10. Emerging Drugs
11. Allergic Conjunctivitis: 7 Major Market Analysis
12. Market Outlook by Country
13. the United States: Market Outlook
14. EU-5 Countries: Market Outlook
15. Japan: Market Outlook
16. Market Drivers
17. Market Barriers
19. Report Methodology
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/q8vsr9/allergic?w=4